Ticker
EDITCompany Name
EDITAS MEDICINE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Free Cash Flow | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 3.42M | $ -204.78M | $ -201.36M |
3/31/2025 | $ 7.07M | $ -215.28M | $ -208.21M |
12/31/2024 | $ 8.83M | $ -219.11M | $ -210.28M |
9/30/2024 | $ 9.59M | $ -191.35M | $ -181.76M |
6/30/2024 | $ 6.91M | $ -171.54M | $ -164.63M |
3/31/2024 | $ 4.75M | $ -151.03M | $ -146.28M |
12/31/2023 | $ 4.72M | $ -136.9M | $ -132.18M |
9/30/2023 | $ 4.04M | $ -156.25M | $ -152.21M |
6/30/2023 | $ 4.41M | $ -169.17M | $ -164.76M |
3/31/2023 | $ 3.69M | $ -167.58M | $ -163.89M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations - CapEx
(=) FCF
FCF for EDITAS MEDICINE INC is calculated as follows: CF - Operations [ $ -98.72M ] - CapEx [ $ 7.39M ]
(=) FCF [ $ -106.11M ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.3K |
---|---|
min | $ -356.66M |
max | $ 390M |
average | $ 28.75M |
median | $ 461K |
std | $ 117.92M |